KRS Capital Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

KRS Capital Management’s Portfolio KRTX Stock Details KRTX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell
2023 Q4	$748K	Buy
2023 Q3	$324K	Buy
2023 Q2	$371K	Buy
2023 Q1	$306K	Buy
2022 Q1	–	Sell
2021 Q4	$39K	Buy